New hope to keep advanced endometrial cancer at bay
NCT ID NCT03617679
Summary
This study tested whether a drug called rucaparib could help keep metastatic or recurrent endometrial cancer from worsening after initial chemotherapy. It involved 79 women who had completed 1-2 prior treatments. Participants were randomly assigned to receive either rucaparib or a placebo pill until their cancer progressed, with the goal of extending the time patients lived without their disease getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.